Apollo Healthtech to List by 2027: Promoters to Remain in Charge
ByAinvest
Tuesday, Aug 12, 2025 8:58 pm ET1min read
APO--
In addition to its strong financial performance, Apollo Healthtech is also investing heavily in artificial intelligence (AI) capabilities. The company plans to double its investment in AI over the next two to three years. This investment includes developing AI tools to read X-rays, scan reports, and even predict the risk of liver fibrosis. Apollo Healthtech has partnered with Microsoft to develop these AI-based tools, which are currently in the early stages of testing [2].
The company's focus on AI is part of a broader strategy to improve patient diagnosis and decisions related to medical procedures. This investment aligns with the growing trend among large private hospital chains in India to adopt AI technologies to enhance their services. Apollo Healthtech's overall bed capacity is expected to increase by 4,370 beds over the next 3-4 years through acquisitions, new hospitals, and expansions of existing facilities.
Apollo Healthtech's Q1 total revenue rose by 15% to ₹58.42 billion, beating estimates of ₹57.44 billion. The company expects double-digit revenue growth for the current financial year. Despite a dip in overall occupancy rates, in-patient volume grew by 3% and average revenue per in-patient increased by 9% [1].
References:
[1] https://www.reuters.com/world/india/indias-apollo-hospitals-double-ai-investments-beats-profit-estimate-2025-08-12/
[2] https://www.reuters.com/world/india/apollo-hospitals-q1-profit-rises-strong-demand-2025-08-12/
MSFT--
Apollo Healthtech, the demerged business of Apollo Hospitals, is targeting a listing by January-March 2027. The company's CFO, Krishnan Akhileswaran, said there are no plans for a family reorganization, and the promoters will remain directors in the new company. Apollo Hospitals posted a 42% on-year rise in Q1 consolidated net profit to ₹433 crore, driven by double-digit growth in all business segments.
Apollo Healthtech, the demerged business of Apollo Hospitals, is targeting a listing by January-March 2027. The company's CFO, Krishnan Akhileswaran, confirmed that there are no plans for a family reorganization, and the promoters will remain directors in the new company. Apollo Hospitals posted a 42% on-year rise in Q1 consolidated net profit to ₹433 crore, driven by double-digit growth in all business segments [1].In addition to its strong financial performance, Apollo Healthtech is also investing heavily in artificial intelligence (AI) capabilities. The company plans to double its investment in AI over the next two to three years. This investment includes developing AI tools to read X-rays, scan reports, and even predict the risk of liver fibrosis. Apollo Healthtech has partnered with Microsoft to develop these AI-based tools, which are currently in the early stages of testing [2].
The company's focus on AI is part of a broader strategy to improve patient diagnosis and decisions related to medical procedures. This investment aligns with the growing trend among large private hospital chains in India to adopt AI technologies to enhance their services. Apollo Healthtech's overall bed capacity is expected to increase by 4,370 beds over the next 3-4 years through acquisitions, new hospitals, and expansions of existing facilities.
Apollo Healthtech's Q1 total revenue rose by 15% to ₹58.42 billion, beating estimates of ₹57.44 billion. The company expects double-digit revenue growth for the current financial year. Despite a dip in overall occupancy rates, in-patient volume grew by 3% and average revenue per in-patient increased by 9% [1].
References:
[1] https://www.reuters.com/world/india/indias-apollo-hospitals-double-ai-investments-beats-profit-estimate-2025-08-12/
[2] https://www.reuters.com/world/india/apollo-hospitals-q1-profit-rises-strong-demand-2025-08-12/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet